APA (7th ed.) Citation

Haberman, R. H., Herati, R., Simon, D., Samanovic, M., Blank, R. B., Tuen, M., . . . Scher, J. U. (2021). Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Annals of the rheumatic diseases, 80(10), 1339-1344. https://doi.org/10.1136/annrheumdis-2021-220597

Chicago Style (17th ed.) Citation

Haberman, Rebecca H., et al. "Methotrexate Hampers Immunogenicity to BNT162b2 MRNA COVID-19 Vaccine in Immune-mediated Inflammatory Disease." Annals of the Rheumatic Diseases 80, no. 10 (2021): 1339-1344. https://doi.org/10.1136/annrheumdis-2021-220597.

MLA (9th ed.) Citation

Haberman, Rebecca H., et al. "Methotrexate Hampers Immunogenicity to BNT162b2 MRNA COVID-19 Vaccine in Immune-mediated Inflammatory Disease." Annals of the Rheumatic Diseases, vol. 80, no. 10, 2021, pp. 1339-1344, https://doi.org/10.1136/annrheumdis-2021-220597.